Search
Now showing items 1-3 of 3
Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: A cluster-randomised controlled trial
(Elsevier, 2019)
Novartis Access is a Novartis programme that offers a portfolio of non-communicable disease medicines at a wholesale price of US$1 per treatment per month in low-income and middle-income countries. We evaluated the effect ...
Phone-based monitoring to evaluate health policy and program implementation in Kenya
(Oxford University Press, 2021)
Monitoring and evaluating policies and programs in low- and middle-income countries are often difficult because of the lack of routine data. High mobile phone ownership in these countries presents an
opportunity for ...
Evaluation of pharmaceutical industry led access programmes: A standardised framework
(BMJ Publishing Group, 2019)
Pharmaceutical industry-led access programmes are
increasing in number and scope worldwide. We present
a new standardised framework for evaluation of these
programmes that includes three components: a taxonomy
of 11 ...